Informations générales (source: ClinicalTrials.gov)
Prospective, Observational, Open-label, Clinical Investigation of Intra-articular Arthrosamid® Injection in Subjects With Knee Osteoarthritis
Observational
Contura (Voir sur ClinicalTrials)
avril 2021
janvier 2029
20 septembre 2026
This is a prospective, long-term, observational, all-comers, open-label, multi-centre
clinical investigation enrolling subjects with knee osteoarthritis who is eligible for
treatment with Arthrosamid® according to the Instruction for Use.
Etablissements
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HM hopitaux - Marseille - France | Contact (sur clinicalTrials) | ||||
| Clinique Saint Louis - Poissy - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
- Stated willingness to comply with all study procedures and availability for the
duration of the study
- Male or female, aged ≥ 18 years
- Clinical diagnosis of knee OA
Exclusion Criteria:
- If an active skin disease or infection is present at or near the injection site
- If the joint is infected or severely inflamed
- If a degradable intra-articular injectable such as hyaluronic acid is present, it
must be expected to be absorbed according to manufacturer's information for the
specific product, before injection with Arthrosamid®
- If the patient has previously received treatment with a different non-absorbable
injectable/implant
- If the patient has received a knee alloplasty or has any foreign material in the
knee
- If the patient has undergone knee arthroscopy within the last 6 months
- If the patient has haemophilia or is in uncontrolled anticoagulant treatment